HomeInsightsStock Comparison

Strides Pharma Science Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Strides Pharma Science Ltd vs Sun Pharmaceutical Industries Ltd Stock Comparison

Last Updated on: May 07, 2025

Key Highlights

  • The Latest Trading Price of Strides Pharma Science Ltd is ₹ 632.25 as of 07 May 10:58.
  • The P/E Ratio of Strides Pharma Science Ltd changed from 79.4 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Sun Pharmaceutical Industries Ltd changed from 22.5 on March 2020 to 40.6 on March 2024 . This represents a CAGR of 12.53% over 5 years.
  • The Market Cap of Strides Pharma Science Ltd changed from ₹ 2888 crore on March 2020 to ₹ 7192 crore on March 2024 . This represents a CAGR of 20.01% over 5 yearsThe Market Cap of Sun Pharmaceutical Industries Ltd changed from ₹ 84504 crore on March 2020 to ₹ 388812 crore on March 2024 . This represents a CAGR of 35.70% over 5 years.
  • The revenue of Strides Pharma Science Ltd for the Dec '24 is ₹ 1160 crore as compare to the Sep '24 revenue of ₹ 1195 crore. This represent the decline of -2.94% The revenue of Sun Pharmaceutical Industries Ltd for the Dec '24 is ₹ 14141 crore as compare to the Sep '24 revenue of ₹ 13645 crore. This represent the growth of 3.63%.
  • The ebitda of Strides Pharma Science Ltd for the Dec '24 is ₹ 214.45 crore as compare to the Sep '24 ebitda of ₹ 208.49 crore. This represent the growth of 2.86% The ebitda of Sun Pharmaceutical Industries Ltd for the Dec '24 is ₹ 4158 crore as compare to the Sep '24 ebitda of ₹ 4292 crore. This represent the decline of -3.13%.
  • The net profit of Strides Pharma Science Ltd changed from ₹ -9.36 crore to ₹ 90.04 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Sun Pharmaceutical Industries Ltd changed from ₹ 2013 crore to ₹ 2917 crore over 7 quarters. This represents a CAGR of 23.62% .
  • The Dividend Payout of Strides Pharma Science Ltd changed from 104.26 % on March 2020 to 35.08 % on March 2024 . This represents a CAGR of -19.58% over 5 yearsThe Dividend Payout of Sun Pharmaceutical Industries Ltd changed from 29.89 % on March 2020 to 113.33 % on March 2024 . This represents a CAGR of 30.55% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Strides Pharma Science Ltd

  • Strides Pharma Science Limited is a global pharmaceutical company headquartered in Bengaluru, India.
  • The Company mainly operates in the regulated markets including key markets of US, Europe, Australia, South Africa.
  • It has presence in the emerging markets largely in Africa where it has a branded business and is a pre qualified supplier to donor-funded programme though their institutional business. The Company is an integrated manufacturer and exporter of Finished Pharmaceutical Dosage forms for both branded and generic.
  • It manufactures a very wide spectrum of ethical pharmaceutical products, OTC products and nutraceuticals.
  • Their dosage forms range includes tablets, capsules, soft gelatin capsules, parenterals and semisolids.

About Sun Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Limited including its subsidiaries and associates is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets.
  • The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
  • It includes generics, branded generics, complex or difficult to make technology intensive products, over-the-counter (OTC) products, anti-retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and intermediates.
  • The product portfolio of over 2000 high quality molecules covers multiple dosage forms, including tablets, capsules, injectables, sprays, inhalers, drug delivery systems, ointments, creams and liquids.

Strides Pharma Science Ltd News Hub

News

Strides Pharma's US arm acquires four drugs to bolster portfolio

The portfolio consists of liquids and immediate release solid orals which are in the thera...

Read more

30 Apr 2025 07:51

News

Strides Pharma Science announces incorporation of step-down subsidiary

Arco Lab, a wholly owned subsidiary of Strides Pharma Science has incorporated a new wholl...

Read more

11 Apr 2025 15:34

News

Strides Pharma Science announces acquisition of Singapore-based Amexel

Strides Pharma Global (SPG), a step-down wholly-owned subsidiary of Strides Pharma Science...

Read more

15 Mar 2025 15:45

News

Strides Pharma Science appoints director

Strides Pharma Science has appointed Mukta Arora (DIN: 07225715) as Independent Director o...

Read more

31 Jan 2025 10:49

News

Strides Pharma Science announces change in directorate

Strides Pharma Science announced the change in designation of Arun Kumar (DIN: 00084845) f...

Read more

31 Jan 2025 10:50

News

Strides Pharma Science to hold board meeting

Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

25 Jan 2025 09:49

Sun Pharmaceutical Industries Ltd News Hub

News

Sun Pharma and Israel-based Moebius Medical publish two articles on MM-II

Sun Pharmaceutical Industries and Israel-based Moebius Medical announced today the publica...

Read more

24 Apr 2025 09:12

News

Sun Pharmaceutical launches Fexuprazan tablets 40 mg in India

Sun Pharmaceutical Industries has launched Fexuprazan tablets 40 mg in India under the bra...

Read more

07 Apr 2025 09:07

News

Sun Pharma launches Fexuprazan tablets 40 mg in India

The drug, available in 40 mg tablets, is approved as a new treatment for adults with erosi...

Read more

07 Apr 2025 10:23

News

Sun Pharma completes acquisition of Antibe Therapeutics Inc., Canada

Sun Pharmaceutical Industries has completed 100% acquisition of Antibe Therapeutics Inc., ...

Read more

18 Mar 2025 15:01

News

Sun Pharma gains as arm acquires Antibe Therapeutics for $4.5 Million

Sun Pharmaceuticals Industries is a leading global pharmaceutical company with a specialty...

Read more

18 Mar 2025 12:53

News

Sun Pharmaceuticals Industries Ltd soars 0.96%, gains for fifth straight session

Sun Pharmaceuticals Industries Ltd rose for a fifth straight session today. The stock is q...

Read more

17 Mar 2025 13:00

SWOT Analysis Of Strides Pharma Science Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Sun Pharmaceutical Industries Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Strides Pharma Science Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharmaceutical Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Strides Pharma Science Ltd and Sun Pharmaceutical Industries Ltd

Which company has a larger market capitalization, Strides Pharma Science Ltd or Sun Pharmaceutical Industries Ltd?

Market cap of Strides Pharma Science Ltd is 5,974 Cr while Market cap of Sun Pharmaceutical Industries Ltd is 436,379 Cr

What are the key factors driving the stock performance of Strides Pharma Science Ltd and Sun Pharmaceutical Industries Ltd?

The stock performance of Strides Pharma Science Ltd and Sun Pharmaceutical Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Strides Pharma Science Ltd and Sun Pharmaceutical Industries Ltd?

As of May 7, 2025, the Strides Pharma Science Ltd stock price is INR ₹648.25. On the other hand, Sun Pharmaceutical Industries Ltd stock price is INR ₹1818.75.

How do dividend payouts of Strides Pharma Science Ltd and Sun Pharmaceutical Industries Ltd compare?

To compare the dividend payouts of Strides Pharma Science Ltd and Sun Pharmaceutical Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions